Triazine dendrimers for DNA and siRNA delivery: Progress, challenges, and opportunities

MA Mintzer, OM Merkel, T Kissel… - Dendrimer‐Based Drug …, 2012 - Wiley Online Library
Transfection, a term derived from the phrase “infection by transformation,” is the process by
which foreign nucleic acids are introduced into cells. By this process, the phenotype of cells …

Dendrimers in RNAi delivery

JLJ Fuentes, P Ortega… - … Applications of RNAi, 2013 - Wiley Online Library
Dendrimers in RNAi Delivery Page 1 8 Dendrimers in RNAi Delivery Jose Luis Jiménez
Fuentes1, Paula Ortega2, Sara Ferrando-Martınez1, Rafael Gómez2, Manuel Leal3, Javier de …

Dendrimer‐Based Gene Delivery Systems: Administration Routes and In Vivo Evaluation

MJ Santander‐Ortega, IF Uchegbu… - … ‐Based Drug Delivery …, 2012 - Wiley Online Library
Genetic therapies hold the promise of efficacious and safer therapies as they combine high
efficacy with the potential for excellent specificity based on the specific nature of the …

Dendrimers in gene delivery

C Dufès, IF Uchegbu, AG Schätzlein - Advanced drug delivery reviews, 2005 - Elsevier
Dendrimers have unique molecular architectures and properties that make them attractive
materials for the development of nanomedicines. Key properties such as defined …

Delivering siRNA with dendrimers: In vivo applications

V Leiro, S Duque Santos… - Current Gene Therapy, 2017 - ingentaconnect.com
Over the last decades, gene therapy has emerged as a pioneering therapeutic approach to
treat or prevent several diseases. Among the explored strategies, the short-term silencing of …

Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity

OM Merkel, MA Mintzer, D Librizzi… - Molecular …, 2010 - ACS Publications
A family of triazine dendrimers, differing in their core flexibility, generation number, and
surface functionality, was prepared and evaluated for its ability to accomplish RNAi. The …

Dendrimers as non-viral vectors for siRNA delivery

X Liu, P Rocchi, L Peng - New Journal of Chemistry, 2012 - pubs.rsc.org
There is a tremendous interest in moving siRNA therapeutics into a clinical setting for the
treatment of various diseases. This in itself however depends largely on the availability of …

siRNA therapy, challenges and underlying perspectives of dendrimer as delivery vector

R Kumar Tekade, R GS Maheshwari… - Current …, 2015 - ingentaconnect.com
siRNA technology presents a helpful means of gene silencing in mammalian cells.
Advancement in the field includes enhanced attentiveness in the characterization of target …

Dendrimers as DNA carriers

H Arima - Non-viral Gene Therapy: Gene Design and Delivery, 2005 - Springer
6 Conclusion This review has focused on the potential use of dendrimers, the combination of
dendrimers with other transfection techniques, and the use of dendrimer conjugates for DNA …

Dendrimers as drug nanocarriers: the future of gene therapy and targeted therapies in cancer

I Franiak-Pietryga, B Ziemba, B Messmer… - Dendrimers …, 2018 - books.google.com
Synthetic polymers, such as dendrimers, play a critical role in pharmaceutical discovery and
development. Advances in the application of nanotechnology in medicine have given rise to …